Goldman Sachs Group »

Lexeo Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $946k 142k 6.64
2025-03-31 $275k 79k 3.47
2024-12-31 $598k 91k 6.58
2024-09-30 $694k 77k 9.04
2024-06-30 $431k 27k 16.04
2024-03-31 $369k 24k 15.68